Z

Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702

Watchlist Manager
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
Watchlist
Price: 17.31 CNY 2.43% Market Closed
Market Cap: 6B CNY
Have any thoughts about
Zhejiang Tianyu Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Zhejiang Tianyu Pharmaceutical Co Ltd

Current Assets 2.9B
Cash & Short-Term Investments 251.3m
Receivables 567.5m
Other Current Assets 2.1B
Non-Current Assets 3.4B
Long-Term Investments 87.9m
PP&E 2.8B
Intangibles 444.6m
Other Non-Current Assets 26m
Current Liabilities 2.5B
Accounts Payable 436.2m
Accrued Liabilities 74.2m
Short-Term Debt 1.9B
Other Current Liabilities 70m
Non-Current Liabilities 280.2m
Long-Term Debt 214.2m
Other Non-Current Liabilities 66m

Balance Sheet
Zhejiang Tianyu Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
97
145
180
184
262
55
1 152
307
270
232
Cash
0
0
0
0
0
0
0
307
270
232
Cash Equivalents
96
145
180
184
261
55
1 152
0
0
0
Short-Term Investments
0
0
1
2
215
7
38
73
0
0
Total Receivables
181
208
235
246
383
405
525
621
488
615
Accounts Receivables
156
194
207
208
313
322
390
457
367
492
Other Receivables
25
14
29
37
70
83
134
165
122
123
Inventory
248
324
359
461
603
872
995
1 599
2 017
1 890
Other Current Assets
19
24
14
364
123
143
202
232
242
214
Total Current Assets
545
701
789
1 257
1 585
1 481
2 911
2 832
3 018
2 951
PP&E Net
473
532
598
677
872
1 177
1 715
2 491
2 851
2 830
PP&E Gross
0
0
598
677
872
1 177
1 715
2 491
2 851
2 830
Accumulated Depreciation
0
0
291
348
403
475
595
768
993
1 261
Intangible Assets
48
77
113
153
150
166
241
375
424
446
Long-Term Investments
10
10
10
11
11
11
10
79
98
90
Other Long-Term Assets
8
6
5
8
12
6
12
24
26
21
Total Assets
1 085
N/A
1 326
+22%
1 515
+14%
2 107
+39%
2 629
+25%
2 840
+8%
4 890
+72%
5 801
+19%
6 416
+11%
6 338
-1%
Liabilities
Accounts Payable
130
196
191
195
316
286
357
685
649
458
Accrued Liabilities
25
30
36
41
53
70
92
124
131
112
Short-Term Debt
452
567
633
519
665
319
679
909
1 774
1 869
Current Portion of Long-Term Debt
1
1
0
0
10
12
14
93
56
58
Other Current Liabilities
11
25
37
41
76
51
88
65
61
67
Total Current Liabilities
618
818
896
796
1 120
737
1 230
1 877
2 670
2 563
Long-Term Debt
0
0
0
0
0
0
48
121
165
216
Deferred Income Tax
0
0
0
0
0
0
7
14
9
1
Other Liabilities
11
12
11
24
63
66
58
79
76
69
Total Liabilities
629
N/A
831
+32%
908
+9%
819
-10%
1 183
+44%
803
-32%
1 343
+67%
2 091
+56%
2 921
+40%
2 850
-2%
Equity
Common Stock
90
90
90
120
182
182
182
348
348
348
Retained Earnings
252
291
403
473
619
1 177
1 761
1 869
1 715
1 742
Additional Paid In Capital
115
115
115
695
680
704
724
1 493
1 490
1 456
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
34
26
14
0
58
58
Other Equity
0
0
0
0
0
0
894
0
0
0
Total Equity
456
N/A
496
+9%
607
+22%
1 288
+112%
1 447
+12%
2 037
+41%
3 547
+74%
3 709
+5%
3 495
-6%
3 488
0%
Total Liabilities & Equity
1 085
N/A
1 326
+22%
1 515
+14%
2 107
+39%
2 629
+25%
2 840
+8%
4 890
+72%
5 801
+19%
6 416
+11%
6 338
-1%
Shares Outstanding
Common Shares Outstanding
134
134
134
179
180
182
182
348
346
346

See Also

Discover More